Skip to content
healthcare.dev

Truxima

NDC 63459-104, rituximab-abbs, injection, solution, from Cephalon, Inc..

Product NDC
63459-104
Status
Listed
Labeler
Cephalon, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761088
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63459-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RITUXIMAB10 mg/mL

Pharmacologic classes

CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
63459-104-50634590104501 VIAL, SINGLE-USE in 1 CARTON (63459-104-50) / 50 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9af3ddc7-4217-417a-ac89-8704edc5bc44
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63459-104

Use it

Look up 63459-104 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63459-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63459-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.